Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current and future treatments in multiple system atrophy.

Christine D Esper1, Stewart A Factor

  • 1Stewart A. Factor, DO Emory University School of Medicine, Wesley Woods Health Center, 1841 Clifton Road NE, Room 327, Atlanta, GA 30329, USA. sfactor@emory.edu.

Current Treatment Options in Neurology
|April 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Freezing of Gait Levodopa Response Pattern in Parkinson's Disease Provides Clues to Pathophysiology.

The European journal of neuroscience·2026
Same author

Pallidal Deep Brain Stimulation in Dystonia: Investigating Differential Response by Dystonia Distribution.

Tremor and other hyperkinetic movements (New York, N.Y.)·2026
Same author

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same author

Case Definitions and Data Sources for NNCSS Parkinson Disease Surveillance: A Systematic Review.

JAMA network open·2026
Same author

Virtual vs In-Person Neurologic Ambulatory Care: A Case-Control Study of Subsequent Health Care Utilization.

Neurology·2026
Same author

Freezing of the Feet While Seated, but Not While Walking.

Movement disorders clinical practice·2026

Multiple system atrophy (MSA) is a rare neurodegenerative disease with no cure. Current management focuses on symptom relief and supportive care, with research exploring neuroprotection and transplantation for future treatments.

Area of Science:

  • Neuroscience
  • Neurology
  • Clinical Medicine

Background:

  • Multiple system atrophy (MSA) is a rare, atypical parkinsonian neurodegenerative disorder.
  • Characterized by parkinsonism, autonomic dysfunction, and corticospinal or cerebellar abnormalities.
  • MSA progression is typically faster than idiopathic Parkinson's disease, with unknown etiology.

Purpose of the Study:

  • To review current treatment options for Multiple system atrophy (MSA).
  • To discuss emerging therapies including neuroprotection and neurotransplantation.
  • To highlight ongoing research into MSA neuropathology for future therapeutic development.

Main Methods:

  • Literature review of current and emerging treatments for MSA.
  • Analysis of symptomatic and palliative management strategies.

Related Experiment Videos

  • Examination of research advancements in neuroprotection and neurotransplantation.

    • Main Results:

    • Current treatments for MSA are primarily symptomatic and palliative.
    • No available treatments can prevent or slow MSA progression.
    • Emerging therapies in neuroprotection and neurotransplantation show potential.

    Conclusions:

    • Effective treatments to slow or halt MSA progression are lacking.
    • Symptomatic management, palliative care, and patient support are crucial.
    • Advancements in understanding MSA neuropathology may yield novel therapies within a decade.